Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current issues on schizoaffective disorder].

J-M Azorin1, A Kaladjian, E Fakra

  • 1SHU de Psychiatrie Adultes, Hôpital Sainte-Marguerite, 270 boulevard Sainte-Marguerite, 13274 Marseille cedex 9.

L'Encephale
|September 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of executive functions and theory of mind in adults with a family history of alcohol use disorder: Combined group and single-case analyses.

Alcohol, clinical & experimental research·2024
Same author

Neural activations during cognitive and affective theory of mind processing in healthy adults with a family history of alcohol use disorder.

Psychological medicine·2023
Same author

Deinstitutionalisation, community-based care and coercion: Did France learn from international experiences?

L'Encephale·2023
Same author

[Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].

L'Encephale·2021
Same author

[Early intervention in bipolar affective disorders: Why, when and how].

L'Encephale·2021
Same author

Psychotropics and COVID-19: An analysis of safety and prophylaxis.

L'Encephale·2021
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Schizoaffective disorder is a common functional psychosis, often presenting between schizophrenia and mood disorders. Optimal pharmacological treatments remain understudied, with atypical antipsychotics recommended despite limited guidelines.

Area of Science:

  • Psychiatry and Neurosciences
  • Clinical Psychology
  • Genetics

Context:

  • Schizoaffective disorder is a significant condition within functional psychosis, accounting for 10-30% of inpatient admissions.
  • Its prevalence is estimated between 0.5-0.8% lifetime.
  • The disorder's definition and classification have evolved since its initial description in 1933, with ongoing debate regarding its position relative to schizophrenia and affective disorders.

Purpose:

  • To review the current understanding of schizoaffective disorder, including its classification, diagnostic criteria, and epidemiological data.
  • To explore the familial patterns, neurobiological underpinnings, and proposed etiological hypotheses.
  • To highlight the challenges in pharmacological treatment and the need for further research.

Summary:

Related Experiment Videos

  • Schizoaffective disorder is characterized by overlapping psychotic and mood symptoms, with diagnostic systems like DSM-IV and ICD-10 showing variations.
  • Familial studies suggest a shared liability with both schizophrenia and affective disorders.
  • Neuroimaging and cognitive studies indicate a position between these disorders, closer to schizophrenia, within a spectrum of functional psychosis.

Impact:

  • Current research supports schizoaffective disorder's placement within a spectrum of functional psychosis, potentially triggered by mood disorder episodes.
  • Despite limited research on optimal pharmacological treatments, atypical antipsychotics are often recommended.
  • Further studies are crucial for refining subtyping and establishing evidence-based treatment guidelines for schizoaffective disorder.